3865 related articles for article (PubMed ID: 6883283)
1. Correlation between response to chemotherapy of human tumors in patients and in nude mice.
Giovanella BC; Stehlin JS; Shepard RC; Williams LJ
Cancer; 1983 Oct; 52(7):1146-52. PubMed ID: 6883283
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapy of human colorectal tumor xenografts in athymic mice with clinically active drugs: 5-fluorouracil and 1-3-bis-(-2-chloroethyl)-1-nitrosourea (BCNU). Comparison with doxorubicin derivatives: 4'deoxydoxorubicin and 4'-O-methyldoxorubicin.
Giuliani FC; Zirvi KA; Kaplan NO; Goldin A
Int J Cancer; 1981 Jan; 27(1):5-13. PubMed ID: 7251230
[TBL] [Abstract][Full Text] [Related]
3. Response to chemotherapy of human, malignant melanoma xenografts in athymic, nude mice.
Fodstad O; Aass N; Pihl A
Int J Cancer; 1980 Apr; 25(4):453-8. PubMed ID: 7372371
[TBL] [Abstract][Full Text] [Related]
4. Chemosensitivity profiles of human cancers assessed by the 6-day SRC assay on serially xenografted tumors.
Aamdal S; Fodstad O; Kaalhus O; Pihl A
Int J Cancer; 1986 Apr; 37(4):579-87. PubMed ID: 3957463
[TBL] [Abstract][Full Text] [Related]
5. Heterotransplants of human tumors in nude mice.
Povlsen CO
Antibiot Chemother (1971); 1980; 28():15-20. PubMed ID: 7416728
[TBL] [Abstract][Full Text] [Related]
6. Xenografts in pharmacologically immunosuppressed mice as a model to test the chemotherapeutic sensitivity of human tumors.
Floersheim GL; Bieri A; Chiodetti N
Int J Cancer; 1986 Jan; 37(1):109-14. PubMed ID: 3455687
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of a "nude" mouse-human tumor panel as a predictive secondary screen for cancer chemotherapeutic agents.
Bellet RE; Danna V; Mastrangelo MJ; Berd D
J Natl Cancer Inst; 1979 Nov; 63(5):1185-8. PubMed ID: 91697
[TBL] [Abstract][Full Text] [Related]
8. Comparison of tumor response in nude mice and in the patients.
Fiebig HH; Schuchhardt C; Henss H; Fiedler L; Löhr GW
Behring Inst Mitt; 1984 May; (74):343-52. PubMed ID: 6477362
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapeutic sensitivity of human colorectal tumor xenografts.
Kopper L; Lapis K; Hegedüs C
Oncology; 1980; 37 Suppl 1():42-50. PubMed ID: 7454200
[TBL] [Abstract][Full Text] [Related]
10. Use of nude mouse xenografts as preclinical drug screens: in vivo activity of established chemotherapeutic agents against melanoma and ovarian carcinoma xenografts.
Taetle R; Rosen F; Abramson I; Venditti J; Howell S
Cancer Treat Rep; 1987 Mar; 71(3):297-304. PubMed ID: 3815395
[TBL] [Abstract][Full Text] [Related]
11. Methodological aspects of the 6-day subrenal capsule assay for measuring the response of human tumors to anticancer agents.
Aamdal S; Fodstad O; Pihl A
Anticancer Res; 1985; 5(4):329-37. PubMed ID: 4037730
[TBL] [Abstract][Full Text] [Related]
12. Experimental chemotherapy of human tumors heterotransplanted in nude mice.
Giovanella BC
Antibiot Chemother (1971); 1980; 28():21-7. PubMed ID: 6998362
[TBL] [Abstract][Full Text] [Related]
13. Variation in response of xenografts of colo-rectal carcinoma to chemotherapy.
Nowak K; Peckham MJ; Steel GG
Br J Cancer; 1978 Apr; 37(4):576-84. PubMed ID: 646928
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of antitumor activity in a human breast tumor/nude mouse model with a special emphasis on treatment dose.
Inaba M; Kobayashi T; Tashiro T; Sakurai Y; Maruo K; Ohnishi Y; Ueyama Y; Nomura T
Cancer; 1989 Oct; 64(8):1577-82. PubMed ID: 2507122
[TBL] [Abstract][Full Text] [Related]
15. Chemotherapy responsiveness of human tumors as first transplant generation xenografts in the normal mouse: six-day subrenal capsule assay.
Bogden AE; Cobb WR; Lepage DJ; Haskell PM; Gulkin TA; Ward A; Kelton DE; Esber HJ
Cancer; 1981 Jul; 48(1):10-20. PubMed ID: 6263448
[TBL] [Abstract][Full Text] [Related]
16. Chemotherapy of human tumor xenografts in genetically athymic mice.
Ovejera AA; Houchens DP; Barker AD
Ann Clin Lab Sci; 1978; 8(1):50-6. PubMed ID: 623430
[TBL] [Abstract][Full Text] [Related]
17. Chemotherapy of a human malignant melanoma transplanted in the nude mouse.
Povlsen CO; Jacobsen GK
Cancer Res; 1975 Oct; 35(10):2790-6. PubMed ID: 1157050
[TBL] [Abstract][Full Text] [Related]
18. New doxorubicin analogs active against doxorubicin-resistant colon tumor xenografts in the nude mouse.
Giuliani FC; Kaplan NO
Cancer Res; 1980 Dec; 40(12):4682-7. PubMed ID: 7438099
[TBL] [Abstract][Full Text] [Related]
19. Antitumor effect of KW2149, a new mitomycin derivative, administered by different modalities.
Nishiyama M; Kim R; Jinushi K; Takagami S; Kirihara Y; Toge T
In Vivo; 1989; 3(6):375-9. PubMed ID: 2519881
[TBL] [Abstract][Full Text] [Related]
20. Activity of mitozolomide (NSC 353451), a new imidazotetrazine, against xenografts from human melanomas, sarcomas, and lung and colon carcinomas.
Fodstad O; Aamdal S; Pihl A; Boyd MR
Cancer Res; 1985 Apr; 45(4):1778-86. PubMed ID: 3978640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
